Mechanism of Action | Levofloxacin is a broad spectrum antibacterial agent. It act by inhibiting the enzyme DNA gyrase (Topoisomerase 2) and Topoisomerase 4.DNA gyrase helps in the formation of a highly condensed three dimensional structure of the DNA by its nicking and closing activity and also by introducing negative supercoil in to the DNA double helix. Levofloxacin inhibits DNA gyrase which results in abnormal linkage between opened DNA and gyrase and negative supercoiling is also impaired. This will inhibits transcription of DNA in to RNA and subsequent protein synthesis. |
PharmacoKinetics | Absorption: It is rapidly and completely absorbed after oral administration. Distribution: It is distributed widely in the body. Metabolism: It undergoes insignificant metabolism in the liver. Excretion: Drug is excreted mainly through urine. |
Half-life | 6-8 hours |
Adverse Effects | 1. Nausea 2. Vomiting 3. Diarrhoea 4. Abdominal discomfort 5. Restlessness 6. Dizziness 7. Drowsiness 8. Arthralgia 9. Rash 10. Confusion 11. Insomnia 12. Anorexia 13. Bad taste 14. Headache 15. Photosensitivity. |
Special Precautions | 1.Hepatic impairment 2.Renal impairment 3.Epilepsy 4.Cerebral arteriosclerosis 5. Caution while driving the vehicle or operating machine or involved in any hazardous activities. 6. Avoid exposure to sun light 7. CNS disease |
Pregnancy | Contraindicated |
Breastfeeding | Contraindicated |
Old Age | Use with caution |
Children | Contraindicated. |
Contraindications | Hypersensitivity to Levofloxacin and other Fluoroquinolones |
Indications | 1.Sinusitis 2.Bronchitis 3.Pneumonia 4.Urinary tract infection 5.Traveler`s diarrhoea 6.Skin and soft tissue infections |
Dosage & Administration | Adults: Dose is determined on the basis of severity of the infection, type of infecting organism, age, weight and renal function of the patient. Sinusitis, Bronchitis, Pneumonia, Skin and soft tissue infections: 500 mg daily for 1 – 2 week Urinary tract infection: 250 mg / day for 10 days Traveler`s diarrhoea: 500 mg / day along with Loperamide |
Schedule | H |
Storage | Store at 25 – 30°C in a tightly closed container. |
Overdose | Give supportive measures and symptomatic treatment. Empty the stomach. Maintain appropriate hydration. |
No customer reviews for the moment.
It is a drug used for certain breast, lung and other cancers. Gefitinib is the first selective inhibitor of epidermal growth factor receptor’s (EGFR) tyrosine kinase domain. Thus Gefitinib is an EGFR inhibitor. The target protein (EGFR) is a family of receptors which includes Her 1(erb-B1), Her 2(erb-B2), and Her 3(erb-B3). EGFR is over expressed in the...
IMACY-100mgTyrosine kinase inhibitors (TKIs) have been approved for cancer treatment and numerous are under investigation. These drugs are rationally designed to target specific tyrosine kinases that are mutated and/or over-expressed in cancer tissues. Ninety-five percent of all chronic myelogenous leukemia (CML) was suggested to be the result of the...
IMACY-400mg n Tyrosine kinase inhibitors (TKIs) have been approved for cancer treatment and numerous are under investigation. These drugs are rationally designed to target specific tyrosine kinases that are mutated and/or over-expressed in cancer tissues.Ninety-five percent of all chronic myelogenous leukemia (CML) was suggested to be the result of the...
BORTENAT2MG INGREDIENT-Bortenat injection contain BortezomibINTRODUCTION-Bortenat 2mg Injection is used in the treatment of multiple myeloma and mantle-cell lymphoma.
DASATINIB-20mgDasatinib is an oral multi- BCR/Abl and Src family tyrosine kinase inhibitor approved for first-line use in patients with chronic myelogenous leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL).Kinase inhibitors prevent the growth of tumours by reducing the action of proteins that control cell...
DASATINIB-50mgDasatinib is an oral multi- BCR/Abl and Src family tyrosine kinase inhibitor approved for first-line use in patients with chronic myelogenous leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL).Kinase inhibitors prevent the growth of tumours by reducing the action of proteins that control cell...
DASATINIB-70mg Dasatinib is an oral multi- BCR/Abl and Src family tyrosine kinase inhibitor approved for first-line use in patients with chronic myelogenous leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL). Kinase inhibitors prevent the growth of tumours by reducing the action of proteins that control cell...
CYNIVE-3(Ivermectin USP 3 mg) This medication is used to treat certain parasitic roundworm infections. In people with weakened defense (immune) systems, curing roundworm infections can reduce the risk of developing a severe or life-threatening infection. Ivermectin belongs to a class of drugs known as anthelmintic. It works by paralyzing and killing...
CYNIVE-6(Ivermectin USP 6 mg) This medication is used to treat certain parasitic roundworm infections. In people with weakened defense (immune) systems, curing roundworm infections can reduce the risk of developing a severe or life-threatening infection. Ivermectin belongs to a class of drugs known as anthelmintic. It works by paralyzing and killing...
CYNIVE-12(Ivermectin USP 12 mg) This medication is used to treat certain parasitic roundworm infections. In people with weakened defense (immune) systems, curing roundworm infections can reduce the risk of developing a severe or life-threatening infection. Ivermectin belongs to a class of drugs known as anthelmintic. It works by paralyzing and killing...
FAVIPIRAVIR - 200 mgFavipiravir was discovered for antiviral activity against the influenza virus by chemical modification of a pyrazine analog in a pyrazine carboxamide derivative (6-fluoro-3-hydroxy-2-pyrazinecarboxamide). It was approved for medical use in 2014, for the treatment of the new or re-emerging pandemic influenza virus infections....
FAVIPIRAVIR - 400 mgFavipiravir was discovered for antiviral activity against the influenza virus by chemical modification of a pyrazine analog in a pyrazine carboxamide derivative (6-fluoro-3-hydroxy-2-pyrazinecarboxamide). It was approved for medical use in 2014, for the treatment of the new or re-emerging pandemic influenza virus infections....
FAVIPIRAVIR - 800 mgFavipiravir was discovered for antiviral activity against the influenza virus by chemical modification of a pyrazine analog in a pyrazine carboxamide derivative (6-fluoro-3-hydroxy-2-pyrazinecarboxamide). It was approved for medical use in 2014, for the treatment of the new or re-emerging pandemic influenza virus infections....
MOLNUPIRAVIR - 200 mgMolnupiravir, is an antiviral medication that inhibits the replication of certain RNA viruses. It is used to treat COVID-19 in those infected by SARS-CoV-2.. Molnupiravir is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine and exerts its antiviral action by introducing copying errors during viral RNA...
Pharmacology of Drug: Tenofovir Alafenamide (25mg)
Pirfenidone, a prescription medication, treats idiopathic pulmonary fibrosis by reducing lung scarring and swelling, improving breathing. Take it with food at the same time daily. Common side effects include insomnia, headache, dizziness, nausea, and photosensitivity. Inform your doctor about liver or kidney disease and other medications you’re taking. If...